These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6237064

  • 1. Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats.
    Savelkoul TJ, Oldenburg SJ, Van Oort WJ, Duursma SA.
    Int J Appl Radiat Isot; 1984 Aug; 35(8):709-13. PubMed ID: 6237064
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S, Kalincák M, Machán V.
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [Abstract] [Full Text] [Related]

  • 3. Protein-binding and urinary excretion of 99mTc(Sn)-MDP and 99mTc-MDP.
    Savelkoul TJ, van Ginkel JJ, Grouls RJ, Oldenburg SJ, Duursma SA.
    Int J Nucl Med Biol; 1985 Dec; 12(2):125-31. PubMed ID: 4044141
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ, Oliveri P, García del Río H, Labriola R, Artagaveytía D, Degrossi EB.
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J, Stritzke P, Kröger E, Schneider C, Wasmus G.
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [Abstract] [Full Text] [Related]

  • 7. Experimental drug-induced changes in renal function and biodistribution of 99mTc-MDP.
    McAfee JG, Singh A, Roskopf M, Ritter C, Lyons B, Schoonmaker JE, Thomas FD, Jones D.
    Invest Radiol; 1983 Aug; 18(5):470-8. PubMed ID: 6227584
    [Abstract] [Full Text] [Related]

  • 8. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA.
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [Abstract] [Full Text] [Related]

  • 9. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM.
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [Abstract] [Full Text] [Related]

  • 10. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A, Hutchison N.
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [Abstract] [Full Text] [Related]

  • 11. Localization of Tc-99m MDP in epiphyseal growth plates of rats.
    Christensen SB, Krogsgaard OW.
    J Nucl Med; 1981 Mar; 22(3):237-45. PubMed ID: 6451674
    [Abstract] [Full Text] [Related]

  • 12. Blood flow and bone uptake of 99mTc-labeled methylene diphosphonate.
    Riggs SA, Wood MB, Cooney WP, Kelly PJ.
    J Orthop Res; 1984 Mar; 1(3):236-43. PubMed ID: 6237181
    [Abstract] [Full Text] [Related]

  • 13. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J, Montz R.
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [Abstract] [Full Text] [Related]

  • 14. Changes in renal uptake of Tc-99m methylene diphosphonate (MDP) in stone-forming rats.
    McAfee JG, Thomas FD, Roskopf M, Ritter K, Lyons B, Lilien OM, Schoonmaker JE.
    Invest Radiol; 1984 Oct; 19(6):543-8. PubMed ID: 6239838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J, Roozen AM, Wortelboer MR, Gelsema WJ, de Ligny CL.
    Int J Rad Appl Instrum B; 1988 Oct; 15(5):479-87. PubMed ID: 3254872
    [No Abstract] [Full Text] [Related]

  • 17. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
    Schuemichen C, Krause T, Umbach G, Wolff T.
    Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
    [Abstract] [Full Text] [Related]

  • 18. Uptake and localization of 99mTc-methylene diphosphonate in mouse osteosarcoma.
    Nakashima H, Ochi H, Yasui N, Hamada H, Ono K.
    Eur J Nucl Med; 1982 Feb; 7(12):531-5. PubMed ID: 6218993
    [Abstract] [Full Text] [Related]

  • 19. Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.
    Knop J, Kröger E, Stritzke P, Schneider C, Kruse HP.
    Eur J Nucl Med; 1981 Feb; 6(2):63-7. PubMed ID: 6451429
    [Abstract] [Full Text] [Related]

  • 20. [Radiochemical purity and stability of 99mTc-MDP for bone scintigraphy (author's transl)].
    Yoshino T, Watanabe N, Kawahara Y, Okada K, Nishimura I.
    Radioisotopes; 1980 Aug; 29(8):398-400. PubMed ID: 6451900
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.